Test Code ACRN Acylcarnitines, Quantitative, Plasma
Necessary Information
1. Patient's age is required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information.
Specimen Required
Patient Preparation: Collect specimen just prior to a scheduled meal or feeding.
Collection Container/Tube:
Preferred: Green top (sodium heparin)
Acceptable: Lavender top (EDTA) or green top (lithium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.1 mL
Collection Instructions: Centrifuge and aliquot plasma into plastic vial.
Useful For
Diagnosis of fatty acid oxidation disorders and several organic acidurias using plasma specimens
Evaluating treatment during follow-up of patients with fatty acid beta-oxidation disorders and several organic acidurias
Method Name
Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS)
Reporting Name
Acylcarnitines, Quantitative, PSpecimen Type
PlasmaSpecimen Minimum Volume
0.04 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen (preferred) | 92 days | |
Refrigerated | 64 days | ||
Ambient | 8 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
≤7 days (nmol/mL) |
8 days-7 years (nmol/mL) |
≥8 years (nmol/mL) |
|
Acetylcarnitine, C2 |
2.14-15.89 |
2.00-27.57 |
2.00-17.83 |
Acrylylcarnitine, C3:1 |
<0.04 |
<0.05 |
<0.07 |
Propionylcarnitine, C3 |
<0.55 |
<1.78 |
<0.88 |
Formiminoglutamate, FIGLU |
<0.43 |
<0.08 |
<0.14 |
Iso-/Butyrylcarnitine, C4 |
<0.46 |
<1.06 |
<0.83 |
Tiglylcarnitine, C5:1 |
<0.05 |
<0.09 |
<0.11 |
Isovaleryl-/2-Methylbutyrylcarn C5 |
<0.38 |
<0.63 |
<0.51 |
3-OH-iso-/butyrylcarnitine, C4-OH |
<0.13 |
<0.51 |
<0.18 |
Hexenoylcarnitine, C6:1 |
<0.12 |
<0.10 |
<0.15 |
Hexanoylcarnitine, C6 |
<0.14 |
<0.23 |
<0.17 |
3-OH-isovalerylcarnitine, C5-OH |
<0.08 |
<0.12 |
<0.10 |
Benzoylcarnitine |
<0.13 |
<0.07 |
<0.10 |
Heptanoylcarnitine, C7 |
<0.05 |
<0.05 |
<0.06 |
3-OH-hexanoylcarnitine, C6-OH |
<0.08 |
<0.19 |
<0.09 |
Phenylacetylcarnitine |
<0.15 |
<0.22 |
<0.29 |
Salicylcarnitine |
<0.08 |
<0.09 |
<0.09 |
Octenoylcarnitine, C8:1 |
<0.48 |
<0.91 |
<0.88 |
Octanoylcarnitine, C8 |
<0.19 |
<0.45 |
<0.78 |
Malonylcarnitine, C3-DC |
<0.09 |
<0.14 |
<0.26 |
Decadienoylcarnitine, C10:2 |
<0.11 |
<0.12 |
<0.26 |
Decenoylcarnitine, C10:1 |
<0.25 |
<0.46 |
<0.47 |
Decanoylcarnitine, C10 |
<0.27 |
<0.91 |
<0.88 |
Methylmalonyl-/succinylcarn, C4-DC |
<0.05 |
<0.05 |
<0.05 |
3-OH-decenoylcarnitine, C10:1-OH |
<0.12 |
<0.12 |
<0.13 |
Glutarylcarnitine, C5-DC |
<0.06 |
<0.10 |
<0.11 |
Dodecenoylcarnitine, C12:1 |
<0.19 |
<0.37 |
<0.35 |
Dodecanoylcarnitine, C12 |
<0.18 |
<0.35 |
<0.26 |
3-Methylglutarylcarnitine, C6-DC |
<0.28 |
<0.21 |
<0.43 |
3-OH-dodecenoylcarnitine, C12:1-OH |
<0.11 |
<0.10 |
<0.13 |
3-OH-dodecanoylcarnitine, C12-OH |
<0.06 |
<0.09 |
<0.08 |
Tetradecadienoylcarnitine, C14:2 |
<0.09 |
<0.13 |
<0.18 |
Tetradecenoylcarnitine, C14:1 |
<0.16 |
<0.35 |
<0.24 |
Tetradecanoylcarnitine, C14 |
<0.11 |
<0.15 |
<0.12 |
Octanedioylcarnitine, C8-DC |
<0.25 |
<0.19 |
<0.19 |
3-OH-tetradecenoylcarnitine C14:1OH |
<0.06 |
<0.18 |
<0.13 |
3-OH-tetradecanoylcarnitine, C14-OH |
<0.04 |
<0.05 |
<0.08 |
Hexadecenoylcarnitine, C16:1 |
<0.15 |
<0.21 |
<0.10 |
Hexadecanoylcarnitine, C16 |
<0.36 |
<0.52 |
<0.23 |
3-OH-hexadecenoylcarnitine,C16:1-OH |
<0.78 |
<0.36 |
<0.06 |
3-OH-hexadecanoylcarnitine, C16-OH |
<0.10 |
<0.07 |
<0.06 |
Octadecadienoylcarnitine, C18:2 |
<0.12 |
<0.31 |
<0.24 |
Octadecenoylcarnitine, C18:1 |
<0.25 |
<0.45 |
<0.39 |
Octadecanoylcarnitine, C18 |
<0.10 |
<0.12 |
<0.14 |
Dodecanedioylcarnitine, C12-DC |
<0.10 |
<0.04 |
<0.04 |
3-OH-octadecadienoylcarn, C18:2-OH |
<0.04 |
<0.06 |
<0.06 |
3-OH-octadecenoylcarnitine C18:1-OH |
<0.03 |
<0.04 |
<0.06 |
3-OH-octadecanoylcarnitine, C18-OH |
<0.03 |
<0.05 |
<0.03 |
Day(s) Performed
Monday through Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82017
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ACRN | Acylcarnitines, Quantitative, P | 43433-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
82413 | Acylcarnitines, Quantitative, P | 46252-3 |
10288 | Acetylcarnitine, C2 | 30191-1 |
36497 | Acrylylcarnitine, C3:1 | 43235-1 |
10289 | Propionylcarnitine, C3 | 30551-6 |
36498 | Formiminoglutamate, FIGLU | 79628-4 |
10290 | Iso-/Butyrylcarnitine, C4 | 43243-5 |
36499 | Tiglylcarnitine, C5:1 | 51416-6 |
10293 | Isovaleryl-/2-Methylbutyrylcarn C5 | 30531-8 |
36500 | 3-OH-iso-/butyrylcarnitine, C4-OH | 39000-5 |
36501 | Hexenoylcarnitine, C6:1 | 74540-6 |
10295 | Hexanoylcarnitine, C6 | 30358-6 |
36502 | 3-OH-isovalerylcarnitine, C5-OH | 39001-3 |
36503 | Benzoylcarnitine | 39615-0 |
36504 | Heptanoylcarnitine, C7 | 55871-8 |
10297 | 3-OH-hexanoylcarnitine, C6-OH | 30236-4 |
36505 | Phenylacetylcarnitine | 90237-9 |
36506 | Salicylcarnitine | 90238-7 |
10298 | Octenoylcarnitine, C8:1 | 30541-7 |
10299 | Octanoylcarnitine, C8 | 30540-9 |
36507 | Malonylcarnitine, C3-DC | 55940-1 |
36508 | Decadienoylcarnitine, C10:2 | 53471-9 |
10301 | Decenoylcarnitine, C10:1 | 30328-9 |
10302 | Decanoylcarnitine, C10 | 30327-1 |
36509 | Methylmalonyl-/succinylcarn, C4-DC | 51415-8 |
36510 | 3-OH-decenoylcarnitine, C10:1-OH | 82478-9 |
10304 | Glutarylcarnitine, C5-DC | 30349-5 |
10305 | Dodecenoylcarnitine, C12:1 | 30332-1 |
10306 | Dodecanoylcarnitine, C12 | 30331-3 |
36511 | 3-Methylglutarylcarnitine, C6-DC | 39002-1 |
36512 | 3-OH-dodecenoylcarnitine, C12:1-OH | 59195-8 |
10307 | 3-OH-dodecanoylcarnitine, C12-OH | 30233-1 |
10308 | Tetradecadienoylcarnitine, C14:2 | 30564-9 |
10309 | Tetradecenoylcarnitine, C14:1 | 30566-4 |
10310 | Tetradecanoylcarnitine, C14 | 30565-6 |
36513 | Octanedioylcarnitine, C8-DC | 39014-6 |
10311 | 3-OH-tetradecenoylcarnitine C14:1OH | 30190-3 |
10312 | 3-OH-tetradecanoylcarnitine, C14-OH | 30238-0 |
10313 | Hexadecenoylcarnitine, C16:1 | 30357-8 |
10314 | Hexadecanoylcarnitine, C16 | 30356-0 |
10315 | 3-OH-hexadecenoylcarnitine,C16:1-OH | 30235-6 |
10316 | 3-OH-hexadecanoylcarnitine, C16-OH | 30234-9 |
10317 | Octadecadienoylcarnitine, C18:2 | 30534-2 |
10318 | Octadecenoylcarnitine, C18:1 | 30542-5 |
10319 | Octadecanoylcarnitine, C18 | 30560-7 |
36514 | Dodecanedioylcarnitine, C12-DC | 55855-1 |
10320 | 3-OH-octadecadienoylcarn, C18:2-OH | 30237-2 |
10321 | 3-OH-octadecenoylcarnitine C18:1-OH | 30312-3 |
36515 | 3-OH-octadecanoylcarnitine, C18-OH | 35656-8 |
10322 | Comment (ACRN) | 48767-8 |
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.